It facilitates the expression of multiple pro-tumor cytokines (including MCP-1, CXCR4, IL-6, and IL-8), mediates tumor angiogenesis, and may further promote cancer cell proliferation by stimulating the release of PGE2, thus contributing to the development of bladder cancer and chemotherapy resistance (71). This evidence concerns the gene CCL2 and urinary bladder cancer.